Biomarker testing identifies high-risk early-stage NSCLC patients for adjuvant chemotherapy, reducing recurrence risk by 78%. The AIM-HIGH study shows a 96% disease-free survival rate at 24 months ...
Morning Overview on MSN
LazySlide links pathology images with RNA data using foundation models
LazySlide, a new computational tool designed to connect whole-slide pathology images with RNA sequencing data through foundation models, addresses one of the persistent bottlenecks in cancer research: ...
Please provide your email address to receive an email when new articles are posted on . A 14-gene molecular assay may help predict adjuvant chemotherapy benefit in early NSCLC. Patients assigned ...
The fraction, volume and frequency of the patient sample collection; DNA extraction and purification procedures, which greatly influence the performance of the downstream molecular tests. It is worth ...
Assay developers in biopharma and research labs strive to save time, reduce costs, and ensure accurate and reproducible results. In quantitative PCR (qPCR) assays, multiplexing—the simultaneous ...
Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001 Ductal carcinoma in situ (DCIS) is routinely treated with ...
New data supports GraftAssure commercialization effortsMulti-center study featured 249 biopsy-matched patientsProprietary "Combination Model" score outperformed percentage-only measures of dd-cfDNARei ...
Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...
This article offers a comprehensive review of the latest diagnostic tools developed for detecting Monkeypox virus (MPXV), especially in light of recent outbreaks. The authors focus on two major ...
Ultra-rapid digital droplet PCR can measure the levels of tumor cells in a tissue sample in about 15 minutes. (HealthDay News) — Intraoperative ultra-rapid droplet digital polymerase chain reaction ...
Poly(ADP-ribose) polymerase inhibitors (PARPi) have shown promising clinical results in the treatment of ovarian cancer. Analysis of biomarker subgroups consistently revealed higher benefits for ...
LANSING, Mich., April 30, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), a worldwide leader in innovative solutions that help the food and beverage industries ensure safety and quality in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results